Transfus Med Hemother. 2013 Oct;40(5):344-50. doi: 10.1159/000355519. Epub 2013 Sep 19.
Promoting Effects of Heparin on ex vivo Expansion of Megakaryocytopoiesis from Human Cord Blood CD34+ Cells.
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
Anne-Marie Maurer, Altay Gezer
Affiliations
Affiliations
- Department of Hematology, School of Medicine, Marmara University, Istanbul, Turkey.
PMID: 24273488
PMCID: PMC3822282 DOI: 10.1159/000355519
Abstract
INTRODUCTION: Transfusion of ex vivo expanded megakaryocytes (MKs) has been proposed to sustain platelet recovery after cord blood (CB) hematopoietic stem cell transplantation. In this study, we investigated the effects of heparin on ex vivo colony forming unit-megakaryocytes (CFU-MKs) and MKs expansion from CB CD34+ cells.
METHODS: CB CD34+ cells were stimulated by a combination of thrombopoietin (TPO), stem cell factor (SCF), Flt3-Ligand (FL), IL-6, and IL-11 supplemented with autologous serum and heparin during 14 days. Expanded cells were analyzed by flow cytometry and cultured in a CFU-MK assay.
RESULTS: Compared to control cultures, the 5-factor combination with heparin induced significantly (p ≤ 0.05) higher numbers of: CFU-MKs and CD41+ cells on days 7 and 14; CD41+ cells displaying hyperploidy levels (≥8N) on day 14; platelets on day 14. The culture-derived platelets were activated upon collagen stimulation.
CONCLUSION: Heparin can significantly enhance the stimulating effects of a combination of TPO, SCF, FL, IL-6, and IL-11 supplemented with autologous serum on CFU-MK, MK, and platelet production from CB CD34+ cells. This expansion system could represent a promising method to generate CFU-MKs and MKs cells for transfusion to sustain platelet reconstitution following CB transplantation.
Keywords: CD34+ cells; Cord blood; Expansion; Glycosaminoglycan; Megakaryocytopoiesis
References
- Methods Mol Biol. 2004;272:309-22 - PubMed
- Blood. 1998 Jun 1;91(11):4118-26 - PubMed
- Transfus Med Rev. 2010 Jan;24(1):33-43 - PubMed
- Prog Clin Biol Res. 1990;356:41-52 - PubMed
- J Thromb Haemost. 2003 Jul;1(7):1587-92 - PubMed
- Haematologica. 2006 Apr;91(4):445-51 - PubMed
- Blood. 2003 Jun 15;101(12):5061-7 - PubMed
- Cell Transplant. 2000 Jan-Feb;9(1):125-31 - PubMed
- Bone Marrow Transplant. 1999 Aug;24(4):397-403 - PubMed
- Hematology Am Soc Hematol Educ Program. 2009;:147-52 - PubMed
- Haematologica. 2000 Jan;85(1):25-30 - PubMed
- Nature. 1988 Mar 24;332(6162):376-8 - PubMed
- Science. 1996 Feb 23;271(5252):1116-20 - PubMed
- Nature. 1987 Mar 26-Apr 1;326(6111):403-5 - PubMed
- J Biomed Mater Res A. 2011 Mar 15;96(4):682-92 - PubMed
- Blood. 1990 Mar 15;75(6):1234-9 - PubMed
- Blood. 1998 Dec 15;92(12):4641-51 - PubMed
- Br J Haematol. 1994 Nov;88(3):608-12 - PubMed
- Exp Hematol. 2005 Dec;33(12):1537-43 - PubMed
- N Engl J Med. 1998 Nov 26;339(22):1565-77 - PubMed
- Semin Hematol. 2010 Jan;47(1):3-12 - PubMed
- Bone Marrow Transplant. 2000 Apr;25(7):797-9 - PubMed
- Blood. 1988 Mar;71(3):723-7 - PubMed
- Exp Hematol. 1995 Oct;23(11):1212-7 - PubMed
- Int J Hematol. 2000 Apr;71(3):203-10 - PubMed
- J Hematother Stem Cell Res. 2000 Aug;9(4):465-73 - PubMed
- J Cell Physiol. 1996 Jul;168(1):97-104 - PubMed
- Biol Blood Marrow Transplant. 2002;8(7):368-76 - PubMed
- Leukemia. 1988 Dec;2(12):804-9 - PubMed
- Nature. 1994 Jun 16;369(6481):533-8 - PubMed
- Experientia. 1995 Sep 29;51(9-10):914-26 - PubMed
- Bone Marrow Transplant. 1990 Feb;5(2):129-33 - PubMed
- Bone Marrow Transplant. 2008 May;41(9):771-8 - PubMed
- Blood. 1992 Aug 15;80(4):912-9 - PubMed
Publication Types